Reflections from news and commentary of the day
Subscribe To
Posts
Comments
Thursday, July 26, 2018
Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline
Experimental Alzheimer’s drug significantly slowed patients’ cognitive decline: The unexpected and unprecedented results could move the treatment’s makers, Biogen and Eisai, to roll the dice on an early approval.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment